Medicine and Dentistry
Supplementation
100%
Randomized Clinical Trial
100%
Drug Megadose
100%
Multiple Sclerosis
100%
Colecalciferol
100%
Low Drug Dose
43%
Vitamin D
31%
Glatiramer
31%
Proportional Hazards Model
6%
Migraine
6%
Hazard Ratio
6%
Neurology
6%
Hypercalcaemia
6%
Disease Activity
6%
Ureter Stone
6%
Kidney Stone
6%
Expanded Disability Status Scale
6%
25 Hydroxyvitamin D
6%
Topiramate
6%
Keyphrases
High Dose
100%
Randomized Clinical Trial
100%
Relapsing-remitting multiple Sclerosis
100%
Vitamin D3
100%
Vitamin D
25%
Glatiramer Acetate
25%
Relapsing-remitting MS
18%
International Units
18%
Multiple Sclerosis
12%
Clinical Relapse
12%
Neuroscience
6%
United States
6%
Hazard Ratio
6%
Cox Proportional Hazards Model
6%
Black Participants
6%
Concomitant Treatment
6%
Migraine
6%
Disease Activity
6%
Safety Analysis
6%
Kaplan-Meier
6%
Hypercalcemia
6%
Expanded Disability Status Scale
6%
Nephrolithiasis
6%
Neurology Clinic
6%
Serum 25-hydroxyvitamin D
6%
Vitamin D Deficiency
6%
Topiramate
6%
Multiple Sclerosis Relapse
6%
Ureterolithiasis
6%
Copaxone
6%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Clinical Trial
100%
Multiple Sclerosis
100%
Cholecalciferol
100%
Vitamin D
31%
Glatiramer
31%
Disease Activity
6%
Nephrolithiasis
6%
Migraine
6%
Hypercalcaemia
6%
25 Hydroxyvitamin D
6%
Ureter Stone
6%
Topiramate
6%
Expanded Disability Status Scale
6%